Effect of Hyperforin-Enriched Extract on Pro-Ejaculatory Effect of 8-Hydroxy-2-(Di-N-Propylamino)Tetralin in Anesthetized Rats

Urology

Volumn 70, Issue 4, 2007, Pages 813-816

  Thomas, Catherine A ^a   Tyagi, Shachi ^a   Yoshimura, Naoki ^a   Chancellor, Michael B ^a   Tyagi, Pradeep ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; HYPERFORIN; URETHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BULBOSPONGIOSUS MUSCLE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ELECTRODE; ELECTROMYOGRAM; MALE; MUSCLE; MUSCLE CONTRACTION; NONHUMAN; OUTCOME ASSESSMENT; PREMATURE EJACULATION; PRIORITY JOURNAL; RAT; SPINAL CORD TRANSSECTION; SPRAGUE DAWLEY RAT; URETHRA PRESSURE;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BICYCLO COMPOUNDS; EJACULATION; ELECTROMYOGRAPHY; HYPERICUM; MALE; PHLOROGLUCINOL; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN AGONISTS; TERPENES;

EID: 35648945782     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.05.016     Document Type: Article

References (15)

1. deGroat W.C., and Booth A.M. Physiology of male sexual function. Ann Intern Med 92 (1980) 329-331
2. Coolen L.M., Allard J., Truitt W.A., et al. Central regulation of ejaculation. Physiol Behav 83 (2004) 203-215
3. Argiolas A., and Melis M.R. The neurophysiology of the sexual cycle. J Endocrinol Invest 26 (2003) 20-22
4. 2-like receptors mediate the expulsion phase of ejaculation elicited by 8-hydroxy-2-(di-N-propylamino)tetralin in rats. J Pharmacol Exp Ther 316 (2006) 830-834
5. Hull E.M., Muschamp J.W., and Sato S. Dopamine and serotonin: influences on male sexual behavior. Physiol Behav 83 (2004) 291-307
6. Seidman S. Ejaculatory dysfunction and depression: pharmacological and psychobiological interactions. Int J Impot Res 18 suppl 1 (2006) S33-S38
7. Schulte-Lobbert S., Holoubek G., Muller W.E., et al. Comparison of the synaptosomal uptake inhibition of serotonin by St John's wort products. J Pharm Pharmacol 56 (2004) 813-818
8. Capasso R., Borrelli F., Montanaro V., et al. Effects of the antidepressant St. John's wort (Hypericum perforatum) on rat and human vas deferens contractility. J Urol 173 (2005) 2194-2197
9. Barnes J., Anderson L.A., and Phillipson J.D. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol 53 (2001) 583-600
10. Mennini T., and Gobbi M. The antidepressant mechanism of Hypericum perforatum. Life Sci 75 (2004) 1021-1027
11. Cui Y., Ang C.Y., Beger R.D., et al. In vitro metabolism of hyperforin in rat liver microsomal systems. Drug Metab Dispos 32 (2004) 28-34
12. Gobbi M., and Mennini T. Is St John's wort a "Prozac-like" herbal antidepressant?. Trends Pharmacol Sci 22 (2001) 557-559
13. Treiber K., Singer A., Henke B., et al. Hyperforin activates nonselective cation channels (NSCCs). Br J Pharmacol 145 (2005) 75-83
14. Hellstrom W.J. Current and future pharmacotherapies of premature ejaculation. J Sex Med 3 suppl 4 (2006) 332-341
15. de Jong T.R., Pattij T., Veening J.G., et al. Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine. Psychopharmacology (Berl) 179 (2005) 509-515